Olema Pharmaceuticals (OLMA) Shares Issued (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Shares Issued of $8.4 million for Q1 2026, up 3472.03% year-over-year from $236000.0 in Q1 2025, and up 6.98% quarter-over-quarter from $7.9 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Shares Issued (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Shares Issued data on file, last reported at $8.4 million in Q1 2026.
- Shares Issued for Q1 2026 came in at $8.4 million, up 3472.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.6 million (up 4.85% YoY), and the FY2025 annual result was $8.4 million, up 402.15% from the prior year.
- Shares Issued advanced to $8.4 million in Q1 2026 per OLMA's latest filing, from $7.9 million in the prior quarter.
- Over five years, Shares Issued peaked at $127.3 million in Q4 2023 and troughed at $7000.0 in Q2 2022.
- A 5-year average of $10.2 million and a median of $413000.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued soared 18928.57% in 2023, then sank 99.54% in 2024.
- A 5-year view of Shares Issued shows it stood at $106000.0 in 2022, then soared by 120008.49% to $127.3 million in 2023, then slumped by 99.54% to $590000.0 in 2024, then jumped by 1235.59% to $7.9 million in 2025, then increased by 6.98% to $8.4 million in 2026.
- Business Quant data shows OLMA's Shares Issued at $8.4 million in Q1 2026, $7.9 million in Q4 2025, and $41000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26,927.15 |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | 8.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.43 Mn |
| Mar 31, 2026 | 8.43 Mn |
| Dec 31, 2025 | 7.88 Mn |
| Dec 31, 2025 | 7.88 Mn |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 234,000.00 |
| Jun 30, 2025 | 234,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 590,000.00 |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 14.90 Mn |
| Jun 30, 2024 | 14.90 Mn |
| Mar 31, 2024 | 920,000.00 |
| Mar 31, 2024 | 920,000.00 |
| Dec 31, 2023 | 127.32 Mn |
| Dec 31, 2023 | 127.32 Mn |